Clinical trial

Antidiabetic Effects on Intrahepatic Fat

NCT03068065

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-01

PhasePHASE4

Study timeline

Study start (actual)2014-05-01Date precision: month

Registry last updated2017-03-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Alcoholic Fatty Liver Diseaseunresolved

Type2 Diabetesunresolved

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

MetforminDRUG · verified · RxNorm: metformin

GliclazideDRUG

Sponsors & collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoollead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03068065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.